Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $569.96 | 9 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Horizon Pharma plc | $354.69 | 3 | $0 (2018) |
| Smith+Nephew, Inc. | $111.68 | 3 | $0 (2021) |
| Organogenesis Inc. | $75.88 | 1 | $0 (2017) |
| ANI Pharmaceuticals, Inc. | $16.70 | 1 | $0 (2024) |
| Tactile Systems Technology Inc | $11.01 | 1 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $16.70 | 1 | ANI Pharmaceuticals, Inc. ($16.70) |
| 2021 | $84.98 | 1 | Smith+Nephew, Inc. ($84.98) |
| 2018 | $267.75 | 5 | Horizon Pharma plc ($230.04) |
| 2017 | $200.53 | 2 | Horizon Pharma plc ($124.65) |
All Payment Transactions
9 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 10/29/2024 | ANI Pharmaceuticals, Inc. | PURIFIED CORTROPHIN GEL (Drug) | Food and Beverage | In-kind items and services | $16.70 | General |
| Category: Treatment of certain chronic autoimmune disorders including acute exacerbations of MS and RA | ||||||
| 11/05/2021 | Smith+Nephew, Inc. | GRAFIX PL (Medical Supply) | Food and Beverage | In-kind items and services | $84.98 | General |
| Category: Other Advanced Wound Management | ||||||
| 07/18/2018 | Horizon Pharma plc | PRIMARY CARE - DISEASE STATE (Drug) | Food and Beverage | Cash or cash equivalent | $125.00 | General |
| Category: NONE | ||||||
| 07/13/2018 | Smith & Nephew, Inc. | Santyl (Drug) | Food and Beverage | In-kind items and services | $11.28 | General |
| Category: Pharma Product | ||||||
| 06/01/2018 | Smith & Nephew, Inc. | Santyl (Drug) | Food and Beverage | In-kind items and services | $15.42 | General |
| Category: Pharma Product | ||||||
| 05/22/2018 | Horizon Pharma plc | KRYSTEXXA (Drug) | Food and Beverage | Cash or cash equivalent | $105.04 | General |
| Category: KRYSTEXXA | ||||||
| 04/18/2018 | Tactile Systems Technology Inc | FLEXITOUCH (Device), ACTITOUCH, ENTRE | Food and Beverage | In-kind items and services | $11.01 | General |
| Category: PNEUMATIC COMPRESSOR | ||||||
| 07/12/2017 | Organogenesis Inc. | Apligraf (Device) | Food and Beverage | Cash or cash equivalent | $75.88 | General |
| Category: Podiatry | ||||||
| 05/25/2017 | Horizon Pharma plc | KRYSTEXXA (Drug) | Food and Beverage | Cash or cash equivalent | $124.65 | General |
| Category: KRYSTEXXA | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 8 | 698 | 1,808 | $188,810 | $78,075 |
| 2022 | 7 | 742 | 1,819 | $190,270 | $77,949 |
| 2021 | 8 | 853 | 1,996 | $202,600 | $87,840 |
| 2020 | 7 | 835 | 1,852 | $160,960 | $71,923 |
All Medicare Procedures & Services
34 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 208 | 561 | $61,710 | $32,869 | 53.3% |
| 11721 | Removal of fingernails or toenails, 6 or more nails | Office | 2023 | 236 | 812 | $85,260 | $23,781 | 27.9% |
| 11056 | Removal of noncancer thickened skin growth, 2-4 growths | Office | 2023 | 114 | 231 | $20,790 | $12,438 | 59.8% |
| 11055 | Removal of noncancer thickened skin growth, 1 growth | Office | 2023 | 51 | 77 | $5,775 | $3,594 | 62.2% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 27 | 27 | $4,725 | $1,936 | 41.0% |
| 10060 | Simple or single drainage of skin abscess | Office | 2023 | 13 | 17 | $3,060 | $1,417 | 46.3% |
| 99347 | Residence visit for established patient with straightforward medical decision making, per day, if using time, at least 15 minutes | Office | 2023 | 12 | 28 | $2,380 | $890.24 | 37.4% |
| 11721 | Removal of fingernails or toenails, 6 or more nails | Facility | 2023 | 23 | 36 | $3,780 | $606.54 | 16.0% |
| 99307 | Subsequent nursing facility care with straightforward level of medical decision making, per day, if using time, at least 10 minutes | Facility | 2023 | 14 | 19 | $1,330 | $542.52 | 40.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 212 | 536 | $58,960 | $32,358 | 54.9% |
| 11721 | Removal of fingernails or toenails, 6 or more nails | Office | 2022 | 250 | 853 | $89,565 | $25,177 | 28.1% |
| 11056 | Removal of noncancer thickened skin growth, 2-4 growths | Office | 2022 | 122 | 231 | $20,790 | $12,014 | 57.8% |
| 11055 | Removal of noncancer thickened skin growth, 1 growth | Office | 2022 | 64 | 88 | $6,600 | $4,154 | 62.9% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 33 | 33 | $5,775 | $2,301 | 39.8% |
| 11721 | Removal of fingernails or toenails, 6 or more nails | Facility | 2022 | 32 | 43 | $4,515 | $757.91 | 16.8% |
| 11057 | Removal of noncancer thickened skin growth, more than 4 growths | Office | 2022 | 14 | 17 | $2,805 | $649.02 | 23.1% |
| 99307 | Follow-up nursing facility visit per day, typically 10 minutes | Facility | 2022 | 15 | 18 | $1,260 | $537.44 | 42.7% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 216 | 504 | $55,440 | $31,073 | 56.0% |
| 11721 | Removal of tissue from 6 or more finger or toe nails | Office | 2021 | 269 | 894 | $89,515 | $27,676 | 30.9% |
| 11056 | Removal of 2 to 4 thickened skin growths | Office | 2021 | 156 | 299 | $26,910 | $15,664 | 58.2% |
| 11055 | Removal of single thickened skin growth | Office | 2021 | 86 | 128 | $9,600 | $5,801 | 60.4% |
| 11057 | Removal of more than 4 thickened skin growths | Office | 2021 | 24 | 33 | $5,315 | $1,967 | 37.0% |
| 10060 | Drainage of abscess | Office | 2021 | 13 | 21 | $3,780 | $1,726 | 45.7% |
| 99203 | New patient outpatient visit, total time 30-44 minutes | Office | 2021 | 19 | 19 | $3,265 | $1,643 | 50.3% |
| 11721 | Removal of tissue from 6 or more finger or toe nails | Facility | 2021 | 43 | 64 | $6,395 | $1,161 | 18.2% |
About Dr. Michael Bodman, DPM
Dr. Michael Bodman, DPM is a Primary Podiatric Medicine healthcare provider based in Fairview Park, Ohio. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 01/30/2006. The National Provider Identifier (NPI) number assigned to this provider is 1386615144.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Michael Bodman, DPM has received a total of $569.96 in payments from pharmaceutical and medical device companies, with $16.70 received in 2024. These payments were reported across 9 transactions from 5 companies. The most common payment nature is "Food and Beverage" ($569.96).
As a Medicare-enrolled provider, Bodman has provided services to 3,128 Medicare beneficiaries, totaling 7,475 services with total Medicare billing of $315,786. Data is available for 4 years (2020–2023), covering 34 distinct procedure/service records.
Practice Information
- Specialty Primary Podiatric Medicine
- Location Fairview Park, OH
- Active Since 01/30/2006
- Last Updated 06/17/2020
- Taxonomy Code 213EP1101X
- Entity Type Individual
- NPI Number 1386615144
Products in Payments
- KRYSTEXXA (Drug) $229.69
- PRIMARY CARE - DISEASE STATE (Drug) $125.00
- GRAFIX PL (Medical Supply) $84.98
- Apligraf (Device) $75.88
- Santyl (Drug) $26.70
- PURIFIED CORTROPHIN GEL (Drug) $16.70
- FLEXITOUCH (Device) $11.01
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.